Results 1 -
10
of
59
for
Breast cancer 3
- ... BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2 BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 3; BROVCA3 BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4; ...
- ... doi: 10.1002/cncr.29010. Epub 2014 Sep 3. Citation on PubMed
- ... germline mutations: a Li-Fraumeni syndrome consortium effort. Breast Cancer Res Treat. 2012 Jun;133(3):1125-30. doi: 10.1007/s10549-012-1993- ...
- ... H, Ohno S, Sasaki Y, Matsuura M. Hereditary breast and ovarian cancer susceptibility genes (review). Oncol Rep. 2013 Sep;30(3):1019-29. doi: 10.3892/or.2013.2541. ...
- ... unknown. More About This Health Condition ADMCKD ADMCKD1 breast carcinoma-associated antigen DF3 CA 15-3 cancer antigen 15-3 carcinoma-associated mucin CD227 DF3 ...
- ... H, Ohno S, Sasaki Y, Matsuura M. Hereditary breast and ovarian cancer susceptibility genes (review). Oncol Rep. 2013 Sep;30(3):1019-29. doi: 10.3892/or.2013.2541. ...
- ... Kyriakidis DA, Gounaris A. Tumor suppressor PTEN in breast cancer: heterozygosity, mutations and protein expression. Anticancer Res. 2014 Mar;34(3):1387-400. Citation on PubMed National Cancer Institute: ...
- ... H, Ohno S, Sasaki Y, Matsuura M. Hereditary breast and ovarian cancer susceptibility genes (review). Oncol Rep. 2013 Sep;30(3):1019-29. doi: 10.3892/or.2013.2541. ...
- ... show that the CYB5R3 gene polymorphism associated with breast cancer occurs at a 90-fold higher rate in African American women than in white women. B5R DIA1 diaphorase-1 NADH-cytochrome b5 reductase 3 NADH-diaphorase 1 NB5R3_HUMAN Tests of CYB5R3 ...
- ... activated protein kinase kinase kinase 1 polymorphisms and breast cancer susceptibility: a meta-analysis of 20 case-control studies. PLoS One. 2014 Mar 4;9(3):e90771. doi: 10.1371/journal.pone.0090771. eCollection ...